date,title,source
Oct-17-18,"Investor Expectations to Drive Momentum within Matthews International, AC Immune SA, Entercom Communications, Sunrun, Axcelis Technologies, and Advanced Disposal Services  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-22-18,"AC Immune Announces Dr. Andreas Muhs, Chief Scientific Officer, to Take Medical Leave of Absence",GlobeNewswire
Oct-25-18,AC Immune Selected to Present Progress on its Tau Morphomer Program in the Late Breaking News Session at CTAD Conference in Barcelona,GlobeNewswire
Oct-29-18,AC Immune Partner Life Molecular Imaging Presents New Clinical Study Results for Tau PET-Tracer 18F-PI-2620,GlobeNewswire
Oct-29-18,AC Immune SA: New Data Supporting Crenezumab as Potential Alzheimer's Therapy,GlobeNewswire
Nov-01-18,AC Immune to Present at 2018 Society for Neurosciences Meeting,GlobeNewswire
Nov-01-18,AC Immune to Host Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and the Involvement of Other Misfolded Proteins in AD and Neurodegenerative Diseases,GlobeNewswire
Nov-05-18,Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline,Zacks
Nov-09-18,AC Immune Shares Insights from Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases,GlobeNewswire
Nov-12-18,AC Immune to Present at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-13-18,"AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-13-18,AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update,GlobeNewswire
Nov-15-18,AC Immune Awarded Third Follow-up Grant from The Michael J. Fox Foundation for First-in-Human Study of a Positron Emission Tomography (PET) Tracer for Parkinson's Disease,GlobeNewswire
Nov-30-18,"AC Immune (ACIU) Shares March Higher, Can It Continue?",Zacks
Dec-06-18,What You Must Know About AC Immune SAs (NASDAQ:ACIU) Beta Value,Simply Wall St.
Dec-07-18,"In Memoriam: Dr. Andreas Muhs CSO, Scientific Leader and Friend has Passed Away",GlobeNewswire
Dec-12-18,Lilly partners with AC Immune for Alzheimer's treatment,Reuters
Dec-12-18,Lilly partners with AC Immune for Alzheimer's treatment,Reuters
Dec-12-18,AC Immune and Lilly Announce License and Collaboration Agreement,GlobeNewswire
Dec-12-18,Lilly partners with AC Immune for Alzheimer's treatment,Reuters
Dec-12-18,Lilly and AC Immune Announce License and Collaboration Agreement,PR Newswire
Dec-13-18,Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug,Zacks
Dec-19-18,WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership,PR Newswire
Dec-19-18,AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership,GlobeNewswire
Jan-03-19,AC Immune Announces Appointment of Dr. Marie Kosco-Vilbois as Chief Scientific Officer,GlobeNewswire
Jan-07-19,Biogen Inks Two Deals to Make Drugs for Neurological Diseases,Zacks
Jan-16-19,Stemline Therapeutics (STML) in Focus: Stock Moves 9.5% Higher,Zacks
Jan-17-19,Moving Average Crossover Alert: AC Immune,Zacks
Jan-22-19,Top Ranked Momentum Stocks to Buy for January 22nd,Zacks
Jan-23-19,Top Ranked Momentum Stocks to Buy for January 23rd,Zacks
Jan-25-19,Top Ranked Momentum Stocks to Buy for January 25th,Zacks
Jan-30-19,Roche Halts Two Late-Stage Studies on Alzheimer's Candidate,Zacks
Jan-30-19,"Roche, AC Immune drop Alzheimer drug trials after setback",Reuters
Jan-30-19,Why AC Immune SA Is Imploding,Motley Fool
Jan-30-19,Genentech kills big drug study in early Alzheimer's patients,American City Business Journals
Jan-30-19,Roche Scraps Alzheimer's Test  But Investors Punished This Stock,Investor's Business Daily
Jan-30-19,Roche drops Alzheimer drug trials after setback,Reuters
Jan-30-19,AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimers Disease,GlobeNewswire
Feb-01-19,AC Immune Enters Oversold Territory,Zacks
